Ilina Ehsan

Leiden, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

CD161 expression and regulation defines rapidly responding effector CD4+ T cells associated with improved survival in HPV16-associated tumors.

CD161 expression and regulation defines rapidly responding effector CD4+ T cells associated with improved survival in HPV16-associated tumors.

Journal: Journal for immunotherapy of cancer
Published: November 21, 2021

Primary vulvar squamous cell carcinomas with high T cell infiltration and active immune signaling are potential candidates for neoadjuvant PD-1/PD-L1 immunotherapy.

Primary vulvar squamous cell carcinomas with high T cell infiltration and active immune signaling are potential candidates for neoadjuvant PD-1/PD-L1 immunotherapy.

Journal: Journal for immunotherapy of cancer
Published: October 01, 2021

CD163+ cytokine-producing cDC2 stimulate intratumoral type 1 T cell responses in HPV16-induced oropharyngeal cancer.

CD163+ cytokine-producing cDC2 stimulate intratumoral type 1 T cell responses in HPV16-induced oropharyngeal cancer.

Journal: Journal for immunotherapy of cancer
Published: June 30, 2020

CD39 Identifies the CD4+ Tumor-Specific T-cell Population in Human Cancer.

CD39 Identifies the CD4+ Tumor-Specific T-cell Population in Human Cancer.

Journal: Cancer immunology research
Published: April 10, 2020

Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial.

Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial.

Journal: Nature communications
Published: December 17, 2019

High numbers of activated helper T cells are associated with better clinical outcome in early stage vulvar cancer, irrespective of HPV or p53 status.

High numbers of activated helper T cells are associated with better clinical outcome in early stage vulvar cancer, irrespective of HPV or p53 status.

Journal: Journal for immunotherapy of cancer
Published: May 28, 2019

Tbet-positive regulatory T cells accumulate in oropharyngeal cancers with ongoing tumor-specific type 1 T cell responses.

Tbet-positive regulatory T cells accumulate in oropharyngeal cancers with ongoing tumor-specific type 1 T cell responses.

Journal: Journal for immunotherapy of cancer
Published: October 11, 2018

NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines.

NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines.

Journal: Cell
Published: June 14, 2018

The Anatomical Location Shapes the Immune Infiltrate in Tumors of Same Etiology and Affects Survival.

The Anatomical Location Shapes the Immune Infiltrate in Tumors of Same Etiology and Affects Survival.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 04, 2018

EGFR signaling suppresses type 1 cytokine-induced T-cell attracting chemokine secretion in head and neck cancer.

EGFR signaling suppresses type 1 cytokine-induced T-cell attracting chemokine secretion in head and neck cancer.

Journal: PloS one
Published: May 09, 2018

Intratumoral HPV16-Specific T Cells Constitute a Type I-Oriented Tumor Microenvironment to Improve Survival in HPV16-Driven Oropharyngeal Cancer.

Intratumoral HPV16-Specific T Cells Constitute a Type I-Oriented Tumor Microenvironment to Improve Survival in HPV16-Driven Oropharyngeal Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 24, 2017

HPV16 E7 DNA tattooing: safety, immunogenicity, and clinical response in patients with HPV-positive vulvar intraepithelial neoplasia.

HPV16 E7 DNA tattooing: safety, immunogenicity, and clinical response in patients with HPV-positive vulvar intraepithelial neoplasia.

Journal: Cancer immunology, immunotherapy : CII
Published: September 30, 2016
Showing 1-12 of 12

Last Updated: 09/26/2026